Medicare Formularies Should Contain “Majority” Of Drugs In Six Classes
Executive Summary
Medicare drug plan formularies will be expected to cover the "majority" of products in six specific drug classes, the Centers for Medicare & Medicaid Services final formulary review guidelines state
You may also be interested in...
Branded Antidepressants Face Challenges With Part D Formulary Positions
The Centers for Medicare & Medicaid Services appears to be interpreting its "all or substantially all" policy for Part D plan coverage of antidepressants as allowing sponsors to include the majority of agents on high cost-sharing tiers, according to analysis of plan formularies conducted by "The Pink Sheet."
Branded Antidepressants Face Challenges With Part D Formulary Positions
The Centers for Medicare & Medicaid Services appears to be interpreting its "all or substantially all" policy for Part D plan coverage of antidepressants as allowing sponsors to include the majority of agents on high cost-sharing tiers, according to analysis of plan formularies conducted by "The Pink Sheet."
CMS Urged To Exempt Mentally Ill From Prior Authorization Under Part D
CMS should require prescription drug plan adherence to consumer-oriented "best practices" rather than allow formulary management tactics that curb benefits for the mentally ill, according to the Medicare Rights Center